£51.67

It has never been this cheap. We have no record of a lower price.

£52 today · cheaper than every other day in the last 3 months

Lippincott Williams & Wilkins Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£51.67 £49.09 £50.12 £51.15 £52.19 £53.22 £54.25 23 July 2026 05 August 2026 19 August 2026 02 September 2026 16 September 2026
View at Amazon ↗

9781975184568

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £52 Days at Price

Price Analysis

Most common price: £52 (56 days, 100.0%)

Price range: £52 - £52

Price levels: 1 different prices over 56 days

Description

Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Drs. Senthil Damodaran and Debu Tripathy of MD Anderson Cancer Center helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of approved or investigational targeted agents and combinations of agents. •Covers breast cancer targets—Phase 1, 2, and 3 trials and preliminary results, as well as approved therapies. •Includes sections on Molecular Targets and Pathways, and Targeted and Immunotherapy Agents. •Contains a section on Molecular Diagnostics, Testing, and Interpretation, with essential content customized for breast cancer. •Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction. •Highlights FDA approvals throughout. •Pocket-sized and color coded to help you find information quickly and easily. Enrich Your eBook Reading Experience •Read directly on your preferred device(s), such as computer, tablet, or smartphone. •Easily convert to audiobook, powering your content with natural language text-to-speech.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
01 October 2022
Listed Since
16 November 2021

Barcode

No barcode data available

Similar Products You Might Like

Cell and Molecular Biology of Breast Cancer
84% match

Cell and Molecular Biology of Breast Cancer

Humana

£80.67 08 Aug 2026
Management of Breast Diseases
82% match

Management of Breast Diseases

Springer

£104.99 14 Sep 2026
Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation
82% match

Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation

Springer

£115.43 14 Sep 2026
Triple-Negative Breast Cancer: A Clinician’s Guide
82% match

Triple-Negative Breast Cancer: A Clinician’s Guide

Springer

£80.67 21 Oct 2026
A Practical Guide to Breast Cancer Treatment
82% match

A Practical Guide to Breast Cancer Treatment

Springer

£115.72 04 Aug 2026
Breast Cancer: Evolving Challenges and Next Frontiers
82% match

Breast Cancer: Evolving Challenges and Next Frontiers

IntechOpen

£119.00 29 Aug 2026
Breast Cancer (MD Anderson Solid Tumor Oncology Series)
81% match

Breast Cancer (MD Anderson Solid Tumor Oncology Series)

Springer

£78.01 13 Aug 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
81% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£103.27 08 Aug 2026
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
81% match

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

Elsevier

£145.99 04 Aug 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
81% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Elsevier

£135.56 05 Aug 2026
Breast Cancer Metastasis and Drug Resistance: Progress and Prospects
81% match

Breast Cancer Metastasis and Drug Resistance: Progress and Prospects

Springer

£125.82 15 Sep 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
81% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£80.65 06 Aug 2026
Integrative Medicine for Breast Cancer: An Evidence-Based Assessment
80% match

Integrative Medicine for Breast Cancer: An Evidence-Based Assessment

Springer

£65.61 05 Aug 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
80% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.21 05 Aug 2026
Changing Paradigms in the Management of Breast Cancer
80% match

Changing Paradigms in the Management of Breast Cancer

Springer

£80.67 14 Sep 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
80% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£156.70 05 Aug 2026
Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)
80% match

Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)

Springer

£88.21 17 Aug 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
80% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.67 21 Oct 2026
Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)
80% match

Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)

Springer

£93.01 14 Sep 2026
Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)
80% match

Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)

Springer

£108.00 07 Aug 2026
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
80% match

Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

Springer

£60.45 08 Aug 2026
Exploring Nanocarriers in Breast Cancer Management
80% match

Exploring Nanocarriers in Breast Cancer Management

Elsevier

£125.02 17 Oct 2026
Current Cancer Therapeutics
80% match

Current Cancer Therapeutics

Springer

£77.47 16 Oct 2026
Imaging-Guided Interventional Breast Techniques
80% match

Imaging-Guided Interventional Breast Techniques

Springer

£119.78 08 Aug 2026